Global Tofacitinib Market Growth 2025-2031

December 2025 | 79 pages | ID: G15CA5C0029EN
LP Information

Abstracts

The global Tofacitinib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Tofacitinib is a prescription medication that belongs to a class of drugs called kinase inhibitors. It is used to treat certain inflammatory conditions in people who have already tried tumor necrosis factor (TNF) blockers. It is a disease modifying anti-rheumatic drug (DMARD), which works by suppressing the immune system. Tofacitinib is available in the form of a tablet (Xeljanz), an extended release tablet (Xeljanz XR) and as an oral solution. It is a janus kinase (JAK) inhibitor, which blocks the activity of the ALK protein, which helps cancer cells grow and spread. Tofacitinib can be used as a first-line treatment or after other treatments have failed.

The future market trends of Tofacitinib are expected to be positive, as the demand for effective and targeted therapies for lung cancer is increasing. Tofacitinib has shown superior efficacy and safety compared to other ALK inhibitors, such as crizotinib, especially in preventing or delaying brain metastases, which are common in ALK-positive NSCLC patients. Moreover, Tofacitinib is being investigated for other indications and combinations, such as ALK-positive anaplastic large cell lymphoma, ROS1-positive NSCLC, and Tofacitinib plus bevacizumab. These factors are likely to boost the market growth of Tofacitinib in the coming years.

LP Information, Inc. (LPI) ' newest research report, the “Tofacitinib Industry Forecast” looks at past sales and reviews total world Tofacitinib sales in 2024, providing a comprehensive analysis by region and market sector of projected Tofacitinib sales for 2025 through 2031. With Tofacitinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tofacitinib industry.

This Insight Report provides a comprehensive analysis of the global Tofacitinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tofacitinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tofacitinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tofacitinib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tofacitinib.

This report presents a comprehensive overview, market shares, and growth opportunities of Tofacitinib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 5mg*60 Tablets
• 5mg*10 Tablets
• 10mg*10 Tablets
• 5mg*30 Tablets
• 5mg*14 Tablets
• 10mg*14 Tablets

Segmentation by Application:

• Rheumatoid Arthritis
• Ulcerative Colitis
• Psoriasis
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Globe Pharmaceuticals
• Delta Pharma Limited
• Beacon Pharmaceuticals
• Drug International

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tofacitinib market?

What factors are driving Tofacitinib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tofacitinib market opportunities vary by end market size?

How does Tofacitinib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tofacitinib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Tofacitinib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Tofacitinib by Country/Region, 2020, 2024 & 2031
2.2 Tofacitinib Segment by Type
  2.2.1 5mg*60 Tablets
  2.2.2 5mg*10 Tablets
  2.2.3 10mg*10 Tablets
  2.2.4 5mg*30 Tablets
  2.2.5 5mg*14 Tablets
  2.2.6 10mg*14 Tablets
2.3 Tofacitinib Sales by Type
  2.3.1 Global Tofacitinib Sales Market Share by Type (2020-2025)
  2.3.2 Global Tofacitinib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Tofacitinib Sale Price by Type (2020-2025)
2.4 Tofacitinib Segment by Application
  2.4.1 Rheumatoid Arthritis
  2.4.2 Ulcerative Colitis
  2.4.3 Psoriasis
  2.4.4 Others
2.5 Tofacitinib Sales by Application
  2.5.1 Global Tofacitinib Sale Market Share by Application (2020-2025)
  2.5.2 Global Tofacitinib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Tofacitinib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Tofacitinib Breakdown Data by Company
  3.1.1 Global Tofacitinib Annual Sales by Company (2020-2025)
  3.1.2 Global Tofacitinib Sales Market Share by Company (2020-2025)
3.2 Global Tofacitinib Annual Revenue by Company (2020-2025)
  3.2.1 Global Tofacitinib Revenue by Company (2020-2025)
  3.2.2 Global Tofacitinib Revenue Market Share by Company (2020-2025)
3.3 Global Tofacitinib Sale Price by Company
3.4 Key Manufacturers Tofacitinib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Tofacitinib Product Location Distribution
  3.4.2 Players Tofacitinib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TOFACITINIB BY GEOGRAPHIC REGION

4.1 World Historic Tofacitinib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Tofacitinib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Tofacitinib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tofacitinib Market Size by Country/Region (2020-2025)
  4.2.1 Global Tofacitinib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Tofacitinib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tofacitinib Sales Growth
4.4 APAC Tofacitinib Sales Growth
4.5 Europe Tofacitinib Sales Growth
4.6 Middle East & Africa Tofacitinib Sales Growth

5 AMERICAS

5.1 Americas Tofacitinib Sales by Country
  5.1.1 Americas Tofacitinib Sales by Country (2020-2025)
  5.1.2 Americas Tofacitinib Revenue by Country (2020-2025)
5.2 Americas Tofacitinib Sales by Type (2020-2025)
5.3 Americas Tofacitinib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tofacitinib Sales by Region
  6.1.1 APAC Tofacitinib Sales by Region (2020-2025)
  6.1.2 APAC Tofacitinib Revenue by Region (2020-2025)
6.2 APAC Tofacitinib Sales by Type (2020-2025)
6.3 APAC Tofacitinib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Tofacitinib by Country
  7.1.1 Europe Tofacitinib Sales by Country (2020-2025)
  7.1.2 Europe Tofacitinib Revenue by Country (2020-2025)
7.2 Europe Tofacitinib Sales by Type (2020-2025)
7.3 Europe Tofacitinib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tofacitinib by Country
  8.1.1 Middle East & Africa Tofacitinib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Tofacitinib Revenue by Country (2020-2025)
8.2 Middle East & Africa Tofacitinib Sales by Type (2020-2025)
8.3 Middle East & Africa Tofacitinib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tofacitinib
10.3 Manufacturing Process Analysis of Tofacitinib
10.4 Industry Chain Structure of Tofacitinib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Tofacitinib Distributors
11.3 Tofacitinib Customer

12 WORLD FORECAST REVIEW FOR TOFACITINIB BY GEOGRAPHIC REGION

12.1 Global Tofacitinib Market Size Forecast by Region
  12.1.1 Global Tofacitinib Forecast by Region (2026-2031)
  12.1.2 Global Tofacitinib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tofacitinib Forecast by Type (2026-2031)
12.7 Global Tofacitinib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Tofacitinib Product Portfolios and Specifications
  13.1.3 Pfizer Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 Globe Pharmaceuticals
  13.2.1 Globe Pharmaceuticals Company Information
  13.2.2 Globe Pharmaceuticals Tofacitinib Product Portfolios and Specifications
  13.2.3 Globe Pharmaceuticals Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Globe Pharmaceuticals Main Business Overview
  13.2.5 Globe Pharmaceuticals Latest Developments
13.3 Delta Pharma Limited
  13.3.1 Delta Pharma Limited Company Information
  13.3.2 Delta Pharma Limited Tofacitinib Product Portfolios and Specifications
  13.3.3 Delta Pharma Limited Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Delta Pharma Limited Main Business Overview
  13.3.5 Delta Pharma Limited Latest Developments
13.4 Beacon Pharmaceuticals
  13.4.1 Beacon Pharmaceuticals Company Information
  13.4.2 Beacon Pharmaceuticals Tofacitinib Product Portfolios and Specifications
  13.4.3 Beacon Pharmaceuticals Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Beacon Pharmaceuticals Main Business Overview
  13.4.5 Beacon Pharmaceuticals Latest Developments
13.5 Drug International
  13.5.1 Drug International Company Information
  13.5.2 Drug International Tofacitinib Product Portfolios and Specifications
  13.5.3 Drug International Tofacitinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Drug International Main Business Overview
  13.5.5 Drug International Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Tofacitinib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Tofacitinib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 5mg*60Tablets
Table 4. Major Players of 5mg*10Tablets
Table 5. Major Players of 10mg*10Tablets
Table 6. Major Players of 5mg*30Tablets
Table 7. Major Players of 5mg*14Tablets
Table 8. Major Players of 10mg*14Tablets
Table 9. Global Tofacitinib Sales by Type (2020-2025) & (K Pcs)
Table 10. Global Tofacitinib Sales Market Share by Type (2020-2025)
Table 11. Global Tofacitinib Revenue by Type (2020-2025) & ($ million)
Table 12. Global Tofacitinib Revenue Market Share by Type (2020-2025)
Table 13. Global Tofacitinib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 14. Global Tofacitinib Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Tofacitinib Sale Market Share by Application (2020-2025)
Table 16. Global Tofacitinib Revenue by Application (2020-2025) & ($ million)
Table 17. Global Tofacitinib Revenue Market Share by Application (2020-2025)
Table 18. Global Tofacitinib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Tofacitinib Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Tofacitinib Sales Market Share by Company (2020-2025)
Table 21. Global Tofacitinib Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Tofacitinib Revenue Market Share by Company (2020-2025)
Table 23. Global Tofacitinib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Tofacitinib Producing Area Distribution and Sales Area
Table 25. Players Tofacitinib Products Offered
Table 26. Tofacitinib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Tofacitinib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Tofacitinib Sales Market Share Geographic Region (2020-2025)
Table 31. Global Tofacitinib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Tofacitinib Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Tofacitinib Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Tofacitinib Sales Market Share by Country/Region (2020-2025)
Table 35. Global Tofacitinib Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Tofacitinib Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Tofacitinib Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Tofacitinib Sales Market Share by Country (2020-2025)
Table 39. Americas Tofacitinib Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Tofacitinib Sales by Type (2020-2025) & (K Pcs)
Table 41. Americas Tofacitinib Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Tofacitinib Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Tofacitinib Sales Market Share by Region (2020-2025)
Table 44. APAC Tofacitinib Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Tofacitinib Sales by Type (2020-2025) & (K Pcs)
Table 46. APAC Tofacitinib Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Tofacitinib Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Tofacitinib Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Tofacitinib Sales by Type (2020-2025) & (K Pcs)
Table 50. Europe Tofacitinib Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Tofacitinib Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Tofacitinib Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Tofacitinib Sales by Type (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Tofacitinib Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Tofacitinib
Table 56. Key Market Challenges & Risks of Tofacitinib
Table 57. Key Industry Trends of Tofacitinib
Table 58. Tofacitinib Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Tofacitinib Distributors List
Table 61. Tofacitinib Customer List
Table 62. Global Tofacitinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. Global Tofacitinib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Tofacitinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Tofacitinib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Tofacitinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Tofacitinib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Tofacitinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Tofacitinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Tofacitinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Tofacitinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Tofacitinib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 73. Global Tofacitinib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Tofacitinib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 75. Global Tofacitinib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Pfizer Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors
Table 77. Pfizer Tofacitinib Product Portfolios and Specifications
Table 78. Pfizer Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Pfizer Main Business
Table 80. Pfizer Latest Developments
Table 81. Globe Pharmaceuticals Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors
Table 82. Globe Pharmaceuticals Tofacitinib Product Portfolios and Specifications
Table 83. Globe Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. Globe Pharmaceuticals Main Business
Table 85. Globe Pharmaceuticals Latest Developments
Table 86. Delta Pharma Limited Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors
Table 87. Delta Pharma Limited Tofacitinib Product Portfolios and Specifications
Table 88. Delta Pharma Limited Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. Delta Pharma Limited Main Business
Table 90. Delta Pharma Limited Latest Developments
Table 91. Beacon Pharmaceuticals Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors
Table 92. Beacon Pharmaceuticals Tofacitinib Product Portfolios and Specifications
Table 93. Beacon Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. Beacon Pharmaceuticals Main Business
Table 95. Beacon Pharmaceuticals Latest Developments
Table 96. Drug International Basic Information, Tofacitinib Manufacturing Base, Sales Area and Its Competitors
Table 97. Drug International Tofacitinib Product Portfolios and Specifications
Table 98. Drug International Tofacitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Drug International Main Business
Table 100. Drug International Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Tofacitinib
Figure 2. Tofacitinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tofacitinib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Tofacitinib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Tofacitinib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Tofacitinib Sales Market Share by Country/Region (2024)
Figure 10. Tofacitinib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 5mg*60Tablets
Figure 12. Product Picture of 5mg*10Tablets
Figure 13. Product Picture of 10mg*10Tablets
Figure 14. Product Picture of 5mg*30Tablets
Figure 15. Product Picture of 5mg*14Tablets
Figure 16. Product Picture of 10mg*14Tablets
Figure 17. Global Tofacitinib Sales Market Share by Type in 2025
Figure 18. Global Tofacitinib Revenue Market Share by Type (2020-2025)
Figure 19. Tofacitinib Consumed in Rheumatoid Arthritis
Figure 20. Global Tofacitinib Market: Rheumatoid Arthritis (2020-2025) & (K Pcs)
Figure 21. Tofacitinib Consumed in Ulcerative Colitis
Figure 22. Global Tofacitinib Market: Ulcerative Colitis (2020-2025) & (K Pcs)
Figure 23. Tofacitinib Consumed in Psoriasis
Figure 24. Global Tofacitinib Market: Psoriasis (2020-2025) & (K Pcs)
Figure 25. Tofacitinib Consumed in Others
Figure 26. Global Tofacitinib Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Tofacitinib Sale Market Share by Application (2024)
Figure 28. Global Tofacitinib Revenue Market Share by Application in 2025
Figure 29. Tofacitinib Sales by Company in 2025 (K Pcs)
Figure 30. Global Tofacitinib Sales Market Share by Company in 2025
Figure 31. Tofacitinib Revenue by Company in 2025 ($ millions)
Figure 32. Global Tofacitinib Revenue Market Share by Company in 2025
Figure 33. Global Tofacitinib Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Tofacitinib Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Tofacitinib Sales 2020-2025 (K Pcs)
Figure 36. Americas Tofacitinib Revenue 2020-2025 ($ millions)
Figure 37. APAC Tofacitinib Sales 2020-2025 (K Pcs)
Figure 38. APAC Tofacitinib Revenue 2020-2025 ($ millions)
Figure 39. Europe Tofacitinib Sales 2020-2025 (K Pcs)
Figure 40. Europe Tofacitinib Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Tofacitinib Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Tofacitinib Revenue 2020-2025 ($ millions)
Figure 43. Americas Tofacitinib Sales Market Share by Country in 2025
Figure 44. Americas Tofacitinib Revenue Market Share by Country (2020-2025)
Figure 45. Americas Tofacitinib Sales Market Share by Type (2020-2025)
Figure 46. Americas Tofacitinib Sales Market Share by Application (2020-2025)
Figure 47. United States Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Tofacitinib Sales Market Share by Region in 2025
Figure 52. APAC Tofacitinib Revenue Market Share by Region (2020-2025)
Figure 53. APAC Tofacitinib Sales Market Share by Type (2020-2025)
Figure 54. APAC Tofacitinib Sales Market Share by Application (2020-2025)
Figure 55. China Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 59. India Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Tofacitinib Sales Market Share by Country in 2025
Figure 63. Europe Tofacitinib Revenue Market Share by Country (2020-2025)
Figure 64. Europe Tofacitinib Sales Market Share by Type (2020-2025)
Figure 65. Europe Tofacitinib Sales Market Share by Application (2020-2025)
Figure 66. Germany Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 67. France Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Tofacitinib Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Tofacitinib Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Tofacitinib Sales Market Share by Application (2020-2025)
Figure 74. Egypt Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Tofacitinib Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Tofacitinib in 2025
Figure 80. Manufacturing Process Analysis of Tofacitinib
Figure 81. Industry Chain Structure of Tofacitinib
Figure 82. Channels of Distribution
Figure 83. Global Tofacitinib Sales Market Forecast by Region (2026-2031)
Figure 84. Global Tofacitinib Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Tofacitinib Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Tofacitinib Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Tofacitinib Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Tofacitinib Revenue Market Share Forecast by Application (2026-2031)